Department of Otolaryngology - Head and Neck Surgery, School of Medicine, Stanford University, Palo Alto, CA.
Immunohorizons. 2024 Sep 1;8(9):688-694. doi: 10.4049/immunohorizons.2400064.
Chronic suppurative otitis media (CSOM) is a neglected disease that afflicts 330 million people worldwide and is the most common cause of permanent hearing loss among children in the developing world. Previously, we discovered that outer hair cell (OHC) loss occurred in the basal turn of the cochlea and that macrophages are the major immune cells associated with OHC loss in CSOM. Macrophage-associated cytokines are upregulated. Specifically, CCL-2, an important member of the MCP family, is elevated over time following middle ear infection. CCR2 is a common receptor of the MCP family and the unique receptor of CCL2. CCR2 knockout mice (CCR2-/-) have been used extensively in studies of monocyte activation in neurodegenerative diseases. In the present study, we investigated the effect of CCR2 deletion on the cochlear immune response and OHC survival in CSOM. The OHC survival rate was 84 ± 12.5% in the basal turn of CCR2+/+ CSOM cochleae, compared with was 63 ± 19.9% in the basal turn of CCR2-/- CSOM cochleae (p ≤ 0.05). Macrophage numbers were significantly reduced in CCR2-/- CSOM cochleae compared with CCR2+/+ CSOM cochleae (p ≤ 0.001). In addition, CCL7 was upregulated, whereas IL-33 was downregulated, in CCR2-/- CSOM cochleae. Finally, the permeability of the blood-labyrinth barrier in the stria vascularis remained unchanged in CCR2-/- CSOM compared with CCR2+/+ CSOM. Taken together, the data suggest that CCR2 plays a protective role through cochlear macrophages in the CSOM cochlea.
慢性化脓性中耳炎(CSOM)是一种被忽视的疾病,影响着全球 3.3 亿人,是发展中国家儿童中最常见的永久性听力损失原因。先前,我们发现外毛细胞(OHC)损失发生在耳蜗的基底回,并且巨噬细胞是与 CSOM 中 OHC 损失相关的主要免疫细胞。巨噬细胞相关细胞因子上调。具体而言,CCL-2 是 MCP 家族的重要成员,在中耳感染后随时间推移而上调。CCR2 是 MCP 家族的常见受体,也是 CCL2 的独特受体。CCR2 敲除小鼠(CCR2-/-)已广泛用于研究单核细胞在神经退行性疾病中的激活。在本研究中,我们研究了 CCR2 缺失对 CSOM 中耳免疫反应和 OHC 存活的影响。CCR2+/+CSOM 耳蜗基底回的 OHC 存活率为 84±12.5%,而 CCR2-/-CSOM 耳蜗基底回的 OHC 存活率为 63±19.9%(p≤0.05)。与 CCR2+/+CSOM 耳蜗相比,CCR2-/-CSOM 耳蜗中的巨噬细胞数量显著减少(p≤0.001)。此外,CCR2-/-CSOM 耳蜗中的 CCL7 上调,而 IL-33 下调。最后,与 CCR2+/+CSOM 相比,CCR2-/-CSOM 耳蜗中的血管纹血迷路屏障通透性保持不变。综上所述,数据表明 CCR2 通过耳蜗巨噬细胞在 CSOM 耳蜗中发挥保护作用。